NASDAQ: ZVSA
Zyversa Therapeutics Inc Stock Ownership - Who owns Zyversa Therapeutics?

Insider buying vs selling

Have Zyversa Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ZVSA insiders and whales buy or sell their stock.

ZVSA Shareholders

What type of owners hold Zyversa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Incon Co Ltd31.37%1,497,199$958.21kInsider
Daniel J. Oconnor28.86%1,377,598$881.66kInsider
Stephen C. Glover10.32%492,756$315.36kInsider
Agp Alliance Global Partners Corp9.36%446,843$285.98kInsider
Larkspur Health LLC4.95%236,273$151.21kInsider
Peter Wolfe0.93%44,585$28.53kInsider
Ubs Group Ag0.59%28,327$18.13kInstitution
Pablo A. Guzman0.55%26,021$16.65kInsider
Geode Capital Management LLC0.45%21,706$13.89kInstitution
Nicholas A. Labella Jr.0.38%18,094$11.58kInsider

1 of 2

ZVSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZVSA1.46%86.94%
SILO5.54%4.53%Net BuyingNet Buying
PBM4.86%95.14%
PCSA1.44%34.14%Net Buying
JAGX0.05%99.95%

Zyversa Therapeutics Stock Ownership FAQ

Who owns Zyversa Therapeutics?

Zyversa Therapeutics (NASDAQ: ZVSA) is owned by 1.46% institutional shareholders, 86.94% Zyversa Therapeutics insiders, and 11.59% retail investors. Incon Co Ltd is the largest individual Zyversa Therapeutics shareholder, owning 1.50M shares representing 31.37% of the company. Incon Co Ltd's Zyversa Therapeutics shares are currently valued at $883.35k.

If you're new to stock investing, here's how to buy Zyversa Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.